💊

Metalyse

tenecteplase

Hjerteinfarkt

✅ Autoriseret

✅

Ingen aktive alarmer

Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.

Hvad det bruges til

Metalyse is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent ST elevation or recent left-bundle-branch block within six hours after the onset of acute-myocardial-infarction symptoms. Metalyse is indicated in adults for the thrombolytic treatment of acute ischaemic stroke (AIS) within 4.5 hours from last known well and after exclusion of intracranial haemorrhage.

⚠️ Patient sikkerhed

📚 Tidligere alarmer (2)

Medium EU løst for 3 år siden

Metalyse

Metalyse Aktivt stof: tenecteplase · Former: Pulver og væske til injektionsvæske · Styrker: 8.000 enheder (40 mg); 10.000 enheder (50 mg) · Anvendelse: Hjerteinfarkt · Alternativer: Ja

Medium EU løst for 3 år siden

Metalyse

INN: tenecteplase · Forms: Powder and solvent for solution for injection · Strengths: 8,000 units (40 mg);10,000 units (50 mg) · Area: Myocardial Infarction · Alternatives: Yes

Officiel EMA-side

https://www.ema.europa.eu/en/medicines/human/EPAR/metalyse